Overview

Gender

male

Peter Fellner (1943) who is British, is currently Chairman of the medical device companies Consort Medical Plc and Optos Plc, and of the biotechnology company, Biotie Therapies Corp. He has also served as Chairman of the U.K. biotechnology company Vernalis plc since April 2003.

He is Vice-Chairman of the US biotechnology company Astex Pharmaceuticals Inc. and serves as a member of the Novo A/S Advisory Group. He was previously Chairman of the life science companies Acambis plc and of Premier Research Group plc, until each was acquired during 2008.

He was Chairman of Celltech Group plc, having previously served as its Chief Executive Officer from 1990 to 2003. He oversaw its development into the U.K.'s largest biotechnology company, and a FTSE 100 constituent, until its acquisition by UCB in 2004.

Before Celltech he was Director of the Roche U.K. Research Centre from 1984 to 1986 then Chief Executive Officer of Roche UK, from 1986 to 1990.